John Ware to Severity of Illness Index
This is a "connection" page, showing publications John Ware has written about Severity of Illness Index.
Connection Strength
0.803
-
Ware JE, Gandek B, Guyer R, Deng N. Standardizing disease-specific quality of life measures across multiple chronic conditions: development and initial evaluation of the QOL Disease Impact Scale (QDIS?). Health Qual Life Outcomes. 2016 Jun 02; 14:84.
Score: 0.362
-
Bruce B, Fries JF, Ambrosini D, Lingala B, Gandek B, Rose M, Ware JE. Better assessment of physical function: item improvement is neglected but essential. Arthritis Res Ther. 2009; 11(6):R191.
Score: 0.231
-
Smith AB, Ware JE, Aluko P, Kulasekaran A. The validity of single-item measures of health-related quality of life across groups differing in acute respiratory symptom severity. Qual Life Res. 2024 Oct; 33(10):2773-2780.
Score: 0.160
-
Menter A, Kosinski M, Bresnahan BW, Papp KA, Ware JE. Impact of efalizumab on psoriasis-specific patient-reported outcomes. Results from three randomized, placebo-controlled clinical trials of moderate to severe plaque psoriasis. J Drugs Dermatol. 2004 Jan-Feb; 3(1):27-38.
Score: 0.038
-
Emery P, Kosinski M, Li T, Martin M, Williams GR, Becker JC, Blaisdell B, Ware JE, Birbara C, Russell AS. Treatment of rheumatoid arthritis patients with abatacept and methotrexate significantly improved health-related quality of life. J Rheumatol. 2006 Apr; 33(4):681-9.
Score: 0.011